Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Govinda Rao Dabburu, Aakriti Jain, Naidu Subbarao & Manish Kumar. (2023) Designing dual inhibitors against potential drug targets of Plasmodium falciparum -M17 Leucyl Aminopeptidase and Plasmepsins. Journal of Biomolecular Structure and Dynamics 41:16, pages 8026-8041.
Read now
Read now
Ashraf A. Abbas, Magda H. Abdellattif & Kamal M. Dawood. (2022) Inhibitory activities of bipyrazoles: a patent review. Expert Opinion on Therapeutic Patents 32:1, pages 63-87.
Read now
Read now
Anu Manhas, Sujeet Kumar & Prakash C. Jha. (2022) Identification of the natural compound inhibitors against Plasmodium falciparum plasmepsin-II via common feature based screening and molecular dynamics simulations. Journal of Biomolecular Structure and Dynamics 40:1, pages 31-43.
Read now
Read now
Articles from other publishers (12)
Pavla Pavlik, Petr Jost, Pavel Rehulka, Vera Vozandychova, Marek Link & Petra Spidlova. (2023) Epigallocatechin gallate inhibits Francisella tularensis growth and suppresses the function of DNA-binding protein HU. Microbial Pathogenesis 176, pages 105999.
Crossref
Crossref
Fatima Ezzahra Bennani, Khalid Karrouchi, Latifa Doudach, Mario Scrima, Noor Rahman, Luca Rastrelli, Trina Ekawati Tallei, Christopher E. Rudd, My El Abbes Faouzi & M’hammed Ansar. (2022) In Silico Identification of Promising New Pyrazole Derivative-Based Small Molecules for Modulating CRMP2, C-RAF, CYP17, VEGFR, C-KIT, and HDAC—Application towards Cancer Therapeutics. Current Issues in Molecular Biology 44:11, pages 5312-5351.
Crossref
Crossref
Sravan Kumar Miryala, Soumya Basu, Aniket Naha, Reetika Debroy, Sudha Ramaiah, Anand Anbarasu & Saravanan Natarajan. (2022) Datasets comprising the quality validations of simulated protein-ligand complexes and SYBYL docking scores of bioactive natural compounds as inhibitors of Mycobacterium tuberculosis protein-targets. Data in Brief 42, pages 108146.
Crossref
Crossref
S.J. Aditya Rao & Nandini P. Shetty. (2022) Structure-based screening of natural product libraries in search of potential antiviral drug-leads as first-line treatment to COVID-19 infection. Microbial Pathogenesis 165, pages 105497.
Crossref
Crossref
Ling Shen, Fuxing Liu, Li Huang, Guangyi Liu, Liqian Zhou & Lihong Peng. (2022) VDA-RWLRLS: An anti-SARS-CoV-2 drug prioritizing framework combining an unbalanced bi-random walk and Laplacian regularized least squares. Computers in Biology and Medicine 140, pages 105119.
Crossref
Crossref
Soumya Basu, Aniket Naha, Balaji Veeraraghavan, Sudha Ramaiah & Anand Anbarasu. (2021) In silico structure evaluation of BAG3 and elucidating its association with bacterial infections through protein–protein and host‐pathogen interaction analysis. Journal of Cellular Biochemistry 123:1, pages 115-127.
Crossref
Crossref
Aniket Naha, Saranya Vijayakumar, Binesh Lal, Baby A. Shankar, Suriya Chandran, Sudha Ramaiah, Balaji Veeraraghavan & Anand Anbarasu. (2021)
Genome sequencing and molecular characterisation of XDR
Acinetobacter baumannii
reveal complexities in resistance: Novel combination of sulbactam–durlobactam holds promise for therapeutic intervention
. Journal of Cellular Biochemistry 122:12, pages 1946-1957.
Crossref
Crossref
Sravan Kumar Miryala, Soumya Basu, Aniket Naha, Reetika Debroy, Sudha Ramaiah, Anand Anbarasu & Saravanan Natarajan. (2021) Identification of bioactive natural compounds as efficient inhibitors against Mycobacterium tuberculosis protein-targets: A molecular docking and molecular dynamics simulation study. Journal of Molecular Liquids 341, pages 117340.
Crossref
Crossref
Abhichandan Das, Upasana Pathak, Sanchaita Rajkhowa & Anupam Nath Jha. 2021. Current Topics and Emerging Issues in Malaria Elimination. Current Topics and Emerging Issues in Malaria Elimination.
Purushothaman Indu, Narasingam Arunagirinathan, Marimuthu Ragavan Rameshkumar, Kodhandan Sangeetha, Angamuthu Divyadarshini & Swaminathan Rajarajan. (2021) Antiviral activity of astragaloside II, astragaloside III and astragaloside IV compounds against dengue virus: Computational docking and in vitro studies. Microbial Pathogenesis 152, pages 104563.
Crossref
Crossref
Kamal M. Dawood & Ashraf A. Abbas. (2021) Synthetic Routes to Bioactive Bipyrazole Derivatives. ChemistrySelect 6:3, pages 279-305.
Crossref
Crossref
Yang Zhang, Tingting Fu, Yuxiang Ren, Fengcheng Li, Guoxun Zheng, Jiajun Hong, Xiaojun Yao, Weiwei Xue & Feng Zhu. (2020) Selective Inhibition of HDAC1 by Macrocyclic Polypeptide for the Treatment of Glioblastoma: A Binding Mechanistic Analysis Based on Molecular Dynamics. Frontiers in Molecular Biosciences 7.
Crossref
Crossref